New pill shows promise against tough cancers
NCT ID NCT06305247
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 31 times
Summary
This study tests a new pill called IPN01194 in adults with advanced solid tumors (cancers that have spread). The goal is to find the right dose and check if it is safe and shrinks tumors. About 36 people with melanoma, colorectal, pancreatic, or head and neck cancers will take the drug by mouth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barcelona - Val D'Hebron
Barcelona, Spain
-
Centre Léon Bérard - Lyon
Lyon, France
-
Fundacion Jimenez Diaz - Madrid
Madrid, Spain
-
IGR-Villejuif
Villejuif, France
-
Institut de Cancerologie de l'Ouest (St-Herblain)
Saint-Herblain, France
-
M.D. Anderson Cancer Center Madrid
Madrid, Spain
-
Paris Saint-Louis
Paris, France
-
Sarah Cannon Research Institute (SCRI) - Nashville
Nashville, Tennessee, 37203, United States
-
The Angeles Clinic and Research Institute - California
Los Angeles, California, 90025, United States
-
Virginia Cancer Specialist
Fairfax, Virginia, 22031, United States
-
Yale Cancer Center - New Heaven
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.